Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group CoHKSE:02279 +5.51%84 OCF Margin % is 26.89% as of Jun. 2026, which is 53% above its 10-year median of 17.53. GuruFocus rates HKSE:02279 with a GF Score™ of 84/100 and a GF Value™ of HK$2.01 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks better than 93.99% on this metric.
The historical rank and industry rank for Yonghe Medical Group Co's OCF Margin % or its related term are showing as below:
HKSE:02279'
s OCF Margin % Range Over the Past 10 Years
Min: -7.68 Med: 17.53 Max: 30.62
Current: 28.54
During the past 8 years, the highest OCF Margin % of Yonghe Medical Group Co was 30.62%. The lowest was -7.68%. And the median was 17.53%.
HKSE:02279's OCF Margin % is ranked better than 93.99% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 8.22
vs HKSE:02279: 28.54
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02279 vs HCA, THC, DVA: OCF Margin % Comparison
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yonghe Medical Group Co (HKSE:02279) has a OCF Margin % of 26.89% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Yonghe Medical Group Co and its competitors. This is 53% above median its historical median of 17.53. According to the industry distribution chart, Yonghe Medical Group Co ranks #40 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 6%.
Is Yonghe Medical Group Co's OCF Margin % too high?
Yonghe Medical Group Co's current OCF Margin % of 26.89% is 53% above median its 10-year median of 17.53. The Healthcare Providers & Services industry median OCF Margin % is 8.22. Yonghe Medical Group Co's value of 26.89% is 227.1% above this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #40 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's OCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #40 out of 666 companies for OCF Margin %. This places Yonghe Medical Group Co in the top 6% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 8.22. Yonghe Medical Group Co's value of 26.89% is 227.1% above this benchmark. While the company's 10-year median is 17.53 vs. the industry median of 8.22, Yonghe Medical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.22, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current OCF Margin % of 26.89% is 227.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current OCF Margin % is 26.89%, which is 53% above median its own 10-year median of 17.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yonghe Medical Group Co (HKSE:02279) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.01, compared to a current price of HK$2.49 — trading 23.9% above its estimated fair value. The current OCF Margin % is 26.89%, which is 53% above median its 10-year median of 17.53 and 227.1% above the Healthcare Providers & Services industry median of 8.22. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Yonghe Medical Group Co (HKSE:02279), the current OCF Margin % is 26.89% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (HKSE:02279) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of HK$2.49 is trading 23.9% above its estimated GF Value™ of HK$2.01.
GuruFocus considers Yonghe Medical Group Co to be Modestly Overvalued.
Key valuation signals for HKSE:02279:
OCF Margin %: 26.89% (53% above median its 10-year median of 17.53)
GF Value™: HK$2.01 vs. price of HK$2.49 (23.9% above fair value)
Industry Position: 227.1% above the Healthcare Providers & Services median (#40 of 666)
No single metric tells the full story. See the HKSE:02279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for HKSE:02279
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02279 has been successfully added to your 
